1 syringe of 1 ml

Rjdephyne is a new range of monophasic products based on cross-linked hyaluronic acid produced through biosynthesis, which is obtained through bacterial fermentation of Streptococcus equi , a natural and non-pathogenic source for humans. After fermentation and purification, eliminating any trace of impurity, the hyaluronic acid thus obtained is in the form of fibers and meets the requirement of the monograph corresponding to the European Pharmacopoeia in force.

Rjdephyne EXTRA
This formulation presents the highest concentration of hyaluronic acid of the Rjdephyne line (26 MG/ML) and the highest elasto-plasticity properties. Indicated for volume increase and redefinition of the oval of the face, facial lipoartrophy, chin, mandibular area with an implant therefore recommended in the deep and medium-deep dermis and in the superficial subcutaneous tissue.

Monophasic gel - HA concentration 26 mg/ml - Dosage 1 ml